Cipla Outlook for the Week (December 26, 2016 – December 30, 2016)
EquityPandit’s Outlook for Cipla for the week (December 26, 2016 – December 30, 2016) : CIPLA: CIPLA closed the week on positive note...
Tag : Cipla
Cipla has received USFDA approval for lipid regulating tablets
The US health regulator has provided its final approval to Cipla for lipid regulating Fenofibrate tablets. Cipla has said in a BSE filing that the...
Cipla Outlook for the Week (December 19, 2016 – December 23, 2016)
EquityPandit’s Outlook for Cipla for the week (December 19, 2016 – December 23, 2016) : CIPLA: CIPLA closed the week on negative note...
Cipla’s Netherlands arm will invest up to euro 16.8 mn in Iranian JV
Cipla has said that its subsidiary in the Netherlands will be investing up to euro 16.8 million (nearly Rs 120 crore) to form a joint...
Cipla Outlook for the Week (December 12, 2016 – December 16, 2016)
EquityPandit’s Outlook for Cipla for the week (December 12, 2016 – December 16, 2016) : CIPLA: CIPLA closed the week on positive note...
Cipla has received USFDA approval for Hepatitis B treatment drug
The USFDA has provided its approval to the drug firm Cipla for marketing Entecavir tablets that are used in the treatment of Hepatitis B infection....
Cipla Outlook for the Week (December 05, 2016 – December 09, 2016)
EquityPandit’s Outlook for Cipla for the week (December 05, 2016 – December 09, 2016) : CIPLA: CIPLA closed the week on positive note gaining around...
Cipla Outlook for the Week (November 28, 2016 – December 02, 2016)
EquityPandit’s Outlook for Cipla for the week (November 28, 2016 – December 02, 2016) : CIPLA: CIPLA closed the week on positive note gaining...
Cipla Outlook for the Week (November 21, 2016 – November 25, 2016)
EquityPandit’s Outlook for Cipla for the week (November 21, 2016 – November 25, 2016) : CIPLA: CIPLA closed the week on positive note...
Cipla Outlook for the Week (November 15, 2016 – November 18, 2016)
EquityPandit’s Outlook for Cipla for the week (November 15, 2016 – November 18, 2016) : CIPLA: CIPLA closed the week on absolutely flat...